Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
The Best Antiretroviral Therapy for Pregnant Women? The Controversy Continues

There's considerable controversy in an area of HIV medicine that one would think should be all but solved by now. It's what HIV treatment we should give pregnant women.

Published
3 hours ago
From
The Body PRO
Experimental HIV therapy may block virus longer with fewer drugs, Florida study says

A new therapy for HIV that does not require a lifelong regimen of daily drug cocktails may be on the horizon if early indications from studies on mice prove effective in people, scientists at the Scripps Research Institute in Florida announced Tuesday in the journal, Cell Reports.

Published
3 hours ago
From
Miami Herald
Gilead’s Updated Version of Tenofovir Performs Well Among Blacks With HIV

Compared with the older tenofovir, called TDF, the new one, TAF, suppressed the virus as well and offered bone, kidney and lipid benefits.

Published
3 hours ago
From
Poz
Gilead Awards $7.5 Million in Second Round of Grants to Advance HIV Cure Research

Gilead Sciences, Inc. today announced the second round of recipients of its HIV cure grants program. This new commitment will provide $7.5 million to support five additional HIV cure research initiatives led by top academic institutions and focused on translational research and efficacy studies in preclinical models.

Published
16 October 2017
From
Gilead press release
Guidelines for the sexual and reproductive health of people living with HIV - consultation open

These BHIVA / BASHH / FSRH guidelines are an update to the 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection (PLWH). They are open for consultation to Friday 8 December 2017.

Published
13 October 2017
From
BHIVA
ART in Africa bridges health gap between those with, without HIV

The expansion of ART for HIV infection has helped reduce disparities in health-related quality of life between HIV-positive and HIV-negative individuals in Zambia and South Africa, according to findings published in The Lancet Global Health.

Published
13 October 2017
From
Healio
Unpacking Michael Weinstein's Latest PrEP Denialism

The controversial head of the AIDS Healthcare Foundation has taken his PrEP-skepticism campaign to the prestigious medical journal AIDS. The editorial is compromised by unsound logic, the cherry picking of evidence and the tendency to ignore important granular details about HIV infection and PrEP-use trends.

Published
13 October 2017
From
Poz
HIV controlled with improved CAR T therapy; human testing planned next spring

A breakthrough cancer treatment is to be tested in patients next year for its original purpose, controlling HIV infection.

Published
13 October 2017
From
The San Diego Union-Tribune
Symtuza protease inhibitor regimen maintains viral suppression for a year

People who switched from a multi-pill antiretroviral regimen to the first one-pill, once-daily regimen that includes a protease inhibitor maintained undetectable viral load for a year, according to

Published
13 October 2017
By
Liz Highleyman
Long-acting monoclonal antibody effective against multidrug-resistant HIV

Ibalizumab, a long-acting monoclonal antibody that prevents HIV from entering cells, maintained viral suppression for a year in people with highly resistant HIV and limited

Published
12 October 2017
By
Liz Highleyman
← First12345...452Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.